20011005
 Genentech and Xoma To Delay FDA Filing For New Psoriasis Drug   The Wall Street Journal,  Oct 5, 2001  The announcement, issued after the stock markets closed, caused shares of the two biopharmaceutical companies to decline in after-hours trading. Trading of Xoma shares was halted for the announcement and they fell 32 cents to $9.76, in 4 p.m. Nasdaq Stock Market trading. In 4 p.m. New York Stock Exchange composite trading, Genentech was at $43.15, down $2.55.   
